Skip to main content
Log in

Simultaneous Determination of Amlodipine and Olmesartan Using HPLC with Fluorescence Detection

  • Published:
Pharmaceutical Chemistry Journal Aims and scope

A sensitive, simple and rapid RP-HPLC method with fluorescence detection has been developed to simultaneously quantify amlodipine besylate (AML) and olmesartan medoxomil (OLM) in their combined pharmaceutical preparation. The method development was divided into three phases. In the first phase, a Plackett-Burman design (PBD) was used to screen five independent factors. The objective of the second phase was to optimize the method performance using a single factor design to obtain the best chromatographic performance for a short run time. Optimum separation was obtained using Lichrospher RP-18 (250 mm × 4.6 mm × 5 μm) column in the isocratic mode using a mobile phase of methanol and 5mM sodium dihydrogen phosphate buffer pH 2.5 (60:40, v/v). The flow rate was maintained at 1.2 mL/min and the detection was performed with a fluorescence detector set at 417 nm (λemission) after excitation at 254 nm (λexcitation). The third phase was method validation according to ICH guidelines. The method was valid in a concentration range of 175 – 325 ng/mL for AML and 250 – 1750 ng/mL for OLM. The proposed method was successfully applied for analysis of the binary mixture of two drugs in their combined pharmaceutical formulation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2.

Similar content being viewed by others

References

  1. British Pharmacopoeia, Department of Health and Social Services and Public Safety, British Pharmacopoeial Commission, London (2010), p. 1504.

  2. United States Pharmacopeia 39 – National Formulary 34, United States Pharmacopeial Convention, Rockville, MD (2005), pp. 5134–5236.

  3. P. Mehulkumar, V. Ramesh, V. Vinay Kumar, et al., Asian J. Res. Chem., 2(2), 127–132 (2009).

    CAS  Google Scholar 

  4. H. W. Darwish, A. H. Bakheit, and A. S. Abdelhameed, Acta Pharm., 66(1), 83 – 95 (2016).

    Article  CAS  Google Scholar 

  5. H. W. Darwish and A. H. Backeit. J. Fluoresc., 23(1), 79 – 91 (2013).

    Article  Google Scholar 

  6. N. A. Inamdar, A. A. Wahid, S. Z. Chemate, et al., Int. J. Biol. Pharm. Res., 6(5), 400 – 405 (2015).

    Google Scholar 

  7. H. M. EL-Fatatry, M. M. Mabrouk, S. F. Hammad, et al., J. Innov. Pharm. Biol. Sci., 3(2), 166 – 181 (2016).

    CAS  Google Scholar 

  8. J. Christian, K. Patel, P. Shah, et al., Int. J. Drug Dev. Res., 7(1), 0975 – 9344 (2015).

    Google Scholar 

  9. H. W. Darwish, A. H. Bakheit, and I. A. Darwish, Dig. J. Nanomater. Biostruct., 7, 1599 – 1608 (2012).

    Google Scholar 

  10. S. K. Shah, D. P. Kawade, A. J. Asnani, et al., Eur. J. Pharm. Med. Res., 3(9), 410 – 415 (2016).

    Google Scholar 

  11. S. Ravichandran, K. Valliappan, and M. Ramanathan, Int. J. Pharm. Pharm. Sci., 7(7), 321 – 324 (2015).

    CAS  Google Scholar 

  12. R. El Sheikh, A. M. Annadi, and A. A. Mohamed, Der Pharma Chem., 10(6), 55 – 61 (2018).

    Google Scholar 

  13. N. Zhang and J. Sun, Chin. J. Pharm., No. 2, 3 (2015).

  14. V. D. Prasad, V. Rangareddy, and P. Aparna, Int. J. Pharm. Sci. Health Care, 5(5) (2015)

  15. Y. Liu and X. Wang., Chin. Pharm., No. 11, 1989 – 1891 (2015).

  16. P. R. Desai, P. J. Mehta, and A. B. Chokshi, Chromatography, 82(5), 819 – 833 (2019).

    Article  CAS  Google Scholar 

  17. A. M. Brondi, J. S. Garcia, and M. G. Trevisan, J. Anal. Meth. Chem., 2017, (2017).

  18. B. P. Mantena, S. V. Rao, D. Suryakala, et al., Anal., Chem. Lett., 6(5), 795 – 819 (2016).

  19. J. R. Kerai, A. J. Vyas, B. Vihol, et al., Pharm. Chem. J., 52(11), 959 – 964 (2019).

    Article  CAS  Google Scholar 

  20. A. De Nicoló, V. Avataneo, F. Rabbia, et al., J. Pharm. Biomed. Anal., 129, 535 – 541 (2016).

    Article  Google Scholar 

  21. G. Geetha, Int. J. Res. Pharm. Sci., 9(2), (2018).

  22. H. Lingeman, W. J. Underberg, A. Takadate, et al., J. Liq. Chromatogr., 8(5), 789 – 874 (1985).

    Article  CAS  Google Scholar 

  23. M. J. Anderson and J. W. Patrick, RSM Simplified: Optimizing Processes Using Response Surface Methods for Design of Experiments, CRC Press, New York (2016).

    Book  Google Scholar 

  24. K. E. Monks, H. J. Rieger, and I. Molnár, J. Pharm. Biomed. Anal., 56(5), 874 – 879 (2011).

    Article  CAS  Google Scholar 

  25. M. J. Anderson and P. J. Whitcomb, Screening Process Factors in the Presence of Interactions, Stat-Ease, Minneapolis (2004).

    Google Scholar 

  26. ICH (Q2 R1), Validation of Analytical Procedures: Text and Methodology, in: Proceedings of International Conference on Harmonization, November (1996).

  27. United States Pharmacopeia and National Formulary (USP 37–NF 32). Rockville, MD (2014).

  28. Olmesartan. https://www.drugbank.ca/drugs/DB00275 [accessed 20 June 2017].

  29. M. Farouk, O. A. EL-Aziz, A. Hemdanb, et al., J. Am. Sci., 7(1), (2011).

  30. Amldipine. https://www.drugbank.ca/drugs/DB00381 [accessed 20 June 2017].

  31. M. Jemal and Y. Q. Xia, Rapid Commun. Mass Spectrom., 13(2), 97 – 106 (1999).

    Article  CAS  Google Scholar 

  32. J. W. Dolan, D. C. Lommen, and L. R. Snyder, J. Chromatogr. A, 485, 91 – 112 (1989).

    CAS  Google Scholar 

  33. A. R. Chabukswar, B. S. Kuchekar, S. C. Jagdale, et al., Arch. Appl. Sci. Res., 2(4), 307 – 312 (2010).

    CAS  Google Scholar 

Download references

CONFLICT OF INTEREST

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Noha Ibrahim.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hassan, S.A., Ibrahim, N., Elzanfaly, E.S. et al. Simultaneous Determination of Amlodipine and Olmesartan Using HPLC with Fluorescence Detection. Pharm Chem J 55, 206–212 (2021). https://doi.org/10.1007/s11094-021-02380-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-021-02380-6

Key words

Navigation